Track market-moving stories before they get noisy

30 Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Did you buy APP securities between February 12, 2026 and August 5, 2026?

Affected APP Investor Summary

Who: AppLovin Corporation (NASDAQ: APP)What: Securities fraud class action lawsuit filedClass Period: February 12, 2026 through August 5, 2026Deadline to Seek Lead Plaintiff Status: November 16, 2026Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company’s projected revenue growth from its AI products and self-service applicationInvestor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery options RADNOR, Pa., Oct. 24, 2026 (GLOBE NEWSWIRE) -- – Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against AppLovin Corporation (AppLovin) (NASDAQ: APP) on behalf of those who purchased or acquired AppLovin securities between February 12, 2026 and August 5, 2026, inclusive. The lawsuit is filed in the United States District Court for the Northern District of California and is captioned Talbot v. AppLovin Corporation, No. 3: 26-cv-10584 (N.D. Cal.).   Investors have until November 16, 2026, to file for lead plaintiff status.  

CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS:
If you purchased or acquired AppLovin securities and have lost money on your investment, please provide your information here: https://www.ktmc.com/app-applovin-corporation-class-action-lawsuit?utm_source=Globe&utm_medium=pressrelease&utm_campaign=app&mktm=PR

You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected]. There is no cost or obligation to speak with an attorney.

To view the AppLovin video on YouTube, click here:
https://youtu.be/Q0nWTDJTg1M?si=h71prPjHwSvP0jEK

APPLOVIN CORPORATION CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY:
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects. Specifically, Defendants misrepresented and/or failed to disclose that: (1) the generative AI video creative feature for the company’s AppLovin Ads platform was subject to significant development delays, making its release on AppLovin’s timeline unlikely; (2) AppLovin overstated the rate of its improvements to its AI models, in turn causing the benefits and reliability of its value proposition of its AI models to be unreliable; and (3) as a result of the foregoing, Defendants’ statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Why did AppLovin’s Stock Drop?
On July 13, 2026, a Bank of America Securities analyst published a note stating that "AppLovin's eCommerce footprint expanded at a slower pace in June" and "[w]eekly data has not shown a clear uptick since AppLovin [Ads] opened to all eComm advertisers on 6/22, suggesting a muted GA start." Accordingly, Bank of America Securities lowered its estimate for AppLovin's annual revenue. On this news, AppLovin's stock price dropped $64.13 per share, or 12.6%, from a closing price of $506.80 per share on July 10, 2026, to close at $442.85 per share on July 13, 2026.

Then, on August 5, 2026, AppLovin reported its financial results for the quarter and revealed, among other things, revenue below consensus estimates. AppLovin attributed the poor results, in part, to delays in the roll out of AppLovin Ads' generative AI video creation tool, which led to lower-than-expected AppLovin Ads revenue and hampered AppLovin's AI "model performance[.]" On this news, AppLovin's stock price dropped $82.13 per share, or 19.6%, from a closing price of $417.80 per share on August 5, 2026, to close at $335.67 per share on August 6, 2026.

WHAT APPLOVIN CORPORATION INVESTORS CAN DO NOW:

File to be lead plaintiff by November 16, 2026.Contact KTMC for a free case evaluation. All representation is on a contingency fee basis, there is no cost to you.Retain counsel of choice or take no action. THE LEAD PLAINTIFF PROCESS FOR APPLOVIN CORPORATION INVESTORS:
AppLovin investors may, no later than November 16, 2026, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.  The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP encourages AppLovin investors to contact the firm for more information.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP (KTMC):

Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including being recognized in Chambers & Partners USA 2026 as a Band 1 Top Firm in Securities and Class Actions, Legal 500’s Tier 1 Rankings for Securities and M&A Litigation, The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent. The complaint in this matter was not filed by KTMC.

CONTACT:

Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
[email protected]

        May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.

Bloom Energy Today

BE

Bloom Energy

$192.52 -25.25 (-11.59%)

As of 10/23/2026 03:59 PM Eastern

This is a fair market value price provided by Massive. Learn more.

$75.70▼

$351.28118.11

$258.36

Bloom Energy’s NYSE: BE Q3 earnings report shows strong growth despite uncertainty surrounding Oracle’s NASDAQ: ORCL force majeure notice. While a headwind, it is offset by numerous tailwinds, and investors must not get this wrong: Bloom's broader growth outlook does not depend solely on Oracle's Project Jupiter, although any significant delay or cancellation would still carry risks.

The project represents roughly 2.4 GW, or about 10% of the 25 GW of potential deployments Bloom has identified, rather than its contracted backlog, which is growing and diversifying across industrial applications. Bloom has other clients to sell to.

Get Bloom Energy alerts:

Oracle’s lean into Bloom Energy fuel cells did what it needed to do for the business: validate them and put them in the spotlight. reported visibility into about 25 GW of potential deployments in Q2, underpinned by a growing number of clients. The critical detail is that Bloom's fuel cells, while not mobile, are modular, portable, easy to install, and production capacity is highly divertible. Oracle’s headwind could become a tailwind for another project, which may now receive its cells sooner than expected.

And the status of Oracle’s Jupiter New Mexico project? The pipeline intended to supply the center is now expected to enter service in February 2027, nearly six months later than originally planned. Oracle and Bloom have since confirmed the deal remains in place, but risks remain. The hang-ups include land and air quality, with New Mexico regulators pushing back against pipeline routes and environmental impact. As it stands, the issues are under review, but the project faces numerous legal challenges, not just those impeding the gas and power. The biggest risk is to Oracle, which took on billions in debt to fund its AI ambitions. While Jupiter is not directly tied to the debt increase, monetizing the asset is critical to its outlook.

Bloom Energy's Q3 Revenue Surges as Guidance Climbs AgainBloom Energy had a very strong quarter, reporting $1.24 billion in net revenue, up 138.1% year over year (YOY) and nearly 16% above expectations. Product sales drove the strength, up 179.4%, with strength in the services and other segments. More importantly, volume leverage is clear in margins: gross margin expanded by more than 400 basis points, adjusted operating margin more than doubled from 8.9% to over 20%, and adjusted earnings per share rose to 94 cents, up 79 cents and 25 cents above forecast.

The catalyst, however, is the guidance. Quarterly strengths and production trends led management to raise guidance for the third consecutive quarter. Revenue is now expected to be $4.5 billion at the midpoint this year, a 122% increase from last year, about 9% above the consensus target, with an equally strong earnings forecast. Earnings are expected to be $3.25 per share at the midpoint, more than four times the 2025 adjusted result, a forecast that could be exceeded.

One reason future results may exceed expectations is a new deal with American Electric Power Company NASDAQ: AEP. Headquartered in Ohio, it serves 11 states, but the new 702-megawatt project is planned near Cheyenne, Wyoming, to serve Google, a subsidiary of Alphabet NASDAQ: GOOGL. The Bloom Energy deal combines its natural gas-fueled, noncombustion fuel cells with planned carbon capture to provide near-zero-emission power for Google data centers. While not immediately accretive, it reflects broader acceptance of Bloom Energy's technology and its growing importance in the distributed, colocated, lower-emissions energy ecosystem.

Wall Street Sees Upside, But Bloom Energy's Risks RemainAnalyst trends have been bullish all year, with coverage rising, sentiment firming, and price targets rising; post-earnings price-target changes have been mixed. Analysts maintain a consensus Moderate Buy rating on Bloom Energy, with price targets suggesting about 20% upside on average and more than 60% at the high end, despite the stock's recent decline.

Bloom Energy Stock Forecast Today12-Month Stock Price Forecast:
$258.36
34.20% Upside

Moderate Buy
Based on 27 Analyst Ratings

Current Price$192.52High Forecast$351.00Average Forecast$258.36Low Forecast$39.00Bloom Energy Stock Forecast Details

The takeaway is that forces beyond the analysts are also in play, including the recent S&P 500 Index addition. It triggered an accumulation wave within an already-correcting market. Up about 2,000% over two years at its high, the market was already pricing in future strength and needed a correction. The narrative today is that the company is still outperforming, still driving a bullish outlook, and setting up for another upswing in its share price. The catalysts are numerous, but the most powerful is advancing the Jupiter project or capturing a deal to offset it.

The biggest risk to investors is dilution (also a factor in stock price action). The company’s capacity ramp costs money and is being funded, at least in part, with share sales. The bad news is that outstanding shares increased by about 5.5% from year-end 2025 through Q3 2026, but there is an upside. Balance sheet highlights reflect a robustly growing, solvent business, with execution as its biggest challenge. Balance sheet details include a flat cash position, increased receivables, contract assets that grew 4x, and higher inventory, outpacing liability gains and leaving equity up 2.5x. The likely outcome is that Bloom Energy’s backlog continues to grow, it converts contracts into capital, and it fuels its flywheel, which is building momentum.

Should You Invest $1,000 in Bloom Energy Right Now?Before you consider Bloom Energy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bloom Energy wasn't on the list.

While Bloom Energy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Kinder Morgan increased its project backlog from $9.6 billion to $14.4 billion in Q3, fueled by $5.4 billion in major natural gas additions. The company now expects full-year adjusted EBITDA to beat budget by more than 6%. Adjusted EPS is expected to exceed budget by more than 13%. KMI approved two major joint venture natural gas projects: The Southeast Connector and the Permian Link pipeline.

Vertiv (NYSE:VRT | VRT Price Prediction) reports third-quarter results on Oct. 28. Shares fell 21.89% over the past month to $194.31.

Picking individual stocks requires time and effort. And investors must possess a certain level of analytical capability to do this successfully. This isn't a viable option for many people.

Another way to invest in the stock market is to buy exchange-traded funds (ETFs). According to Investment Company Institute, there are thousands of U.S. ETFs to choose from. They provide exposure to different asset classes, sectors, geographies, and themes. And they trade as stocks do.

The Vanguard Morningstar Growth ETF (VUG -0.47%) and Vanguard Information Technology ETF (VGT +0.48%) are two high-powered equity options. They have performed well in the past. Between these two investment vehicles, here's which one I believe is the clear long-term winner.

Image source: Getty Images.

Investors will own plenty of growth stocks
The Vanguard Morningstar Growth ETF gives investors a simple way to own America's biggest growth stocks. It tracks the Morningstar U.S. Large Cap Growth Index. This index screens large U.S. companies that post fast sales and earnings growth. The fund holds 135 different businesses.

Concentration deserves attention. The top three holdings are Nvidia, Apple, and Microsoft. The top 10 positions account for 63% of the ETF's total assets. The technology sector, at 72%, features most prominently.

The Vanguard Information Technology ETF provides more targeted exposure. It focuses exclusively on the U.S. technology sector. It tracks the MSCI US Investable Market Information Technology 25/50 Index, which contains tech companies of all sizes. The fund holds 318 stocks.

Investors should also consider its concentration. It's probably no surprise that Nvidia, Apple, and Microsoft are also the top three positions, combined representing 45% of the ETF. By specific industry, semiconductor stocks are the standout. It's not even close, as they have a 38% weighting.

As for cost, the Vanguard Morningstar Growth ETF wins. It charges an expense ratio of 0.03%. That's one-third the price charged by the Vanguard Information Technology ETF (0.09%).

$86.76-$0.41 (-0.47%)

NYSEMKT · As of 4:00 PM ET 10/23/26

Historical performance dramatically favors one ETF
When choosing between two ETFs, investors probably care most about performance. After all, returns show how much wealth can be built over time. That's a headline data point that's impossible to overlook.

In the past decade, the Vanguard Morningstar Growth ETF produced a total return of 420% (as of Oct. 21). This is an impressive showing. It's nearly 100 percentage points ahead of the S&P 500 (^GSPC -0.52%).

But the Vanguard Information Technology ETF's performance is vastly superior. Its trailing decade total return was 775%. A hypothetical $10,000 investment would be worth almost $88,000 today.

Both ETFs have benefited greatly from the artificial intelligence (AI) boom. As discussed, their top three holdings are similar. The difference is that the Vanguard Information Technology ETF has a stronger concentration in these three companies. Nvidia, which has soared 12,910% over the last 10 years, accounts for 17.6% of the portfolio, significantly higher than the Vanguard Morningstar Growth ETF's 13.5% weight.

VGT Vanguard Information Technology ETF$119.17+$0.57 (+0.48%)

NYSEMKT · As of 4:00 PM ET 10/23/26

It's hard not to bet on technology companies
Looking at historical data, the winner is clear. But investors care more about what the future will bring. When figuring out which ETF to add to your portfolio, it goes without saying that adopting a long-term mindset is critical.

If you have 30 years until retirement, as I do, you can afford to take on greater risk. I choose the Vanguard Information Technology ETF. While the Vanguard Morningstar Growth ETF provides more sector diversification, it has been incredibly lucrative to bet on technology companies.

Investors who agree with this line of thinking but don't want to be too aggressive can allocate 5% to 10% of their portfolios to the Vanguard Information Technology ETF. Controlling exposure will also make it easier to navigate volatility, helping you stay invested.

Semtech Corporation (Nasdaq: SMTC), a leading provider of high-performance semiconductors powering AI data center networking and intelligent, connected Internet of Things (“IoT”) devices worldwide, is adding new resilient communications building blocks to its AirLink® 5G Networking Solutions. Semtech will demonstrate the new capabilities in booth #2964 at the International Association of Chiefs of Police (IACP) conference in Orlando, Fla.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261024697343/en/

Semtech’s AirLink XR60, XR80 and XR90 in-vehicle 5G routers support network slicing, FIPS 140-3 and fleet management for public safety agencies.

First responders rely on in-vehicle connectivity for computer-aided dispatch, live video and mobile data. When a mass-casualty incident, large-scale event or natural disaster pushes commercial networks to capacity, public safety traffic can get caught in the same congestion. In a recent survey, 64% of first responders named unreliable network connectivity as their single biggest concern (Source: T-Mobile, “5G and Public Safety: Transforming Emergency Response with T-Priority,” T-Mobile Newsroom, 2025).

“Resilient communication is not a capacity problem; it’s a priority and a data security problem,” said Kinana Hussein, vice president of networking solutions at Semtech. “AirLink networking solutions help address both. Network slicing support gives public safety dedicated, prioritized access to network resources, and AirLink OS 6.1 helps agencies meet FIPS 140-3 through a software update, with no hardware replacement.”

AirLink XR90, XR80 and XR60 Routers

The AirLink XR90, XR80 and XR60 in-vehicle 5G routers are built for public safety fleets. All three are FirstNet Trusted™ for use on FirstNet, built with AT&T, and certified for both T-Mobile’s T-Priority and Verizon’s Frontline network slices, giving agencies dedicated, prioritized access to emergency network resources on either carrier.

FIPS 140-3 and Zero Trust

With the new AirLink OS 6.1 operating system release, compatible AirLink routers can meet the new Federal Information Processing Standards (FIPS) 140-3 through a software update, with no hardware replacement required. FIPS 140-3 replaces FIPS 140-2, whose certificates the National Institute of Standards and Technology’s Cryptographic Module Validation Program (CMVP) moved to its Historical List on Sept. 21, 2026. Semtech’s Zero Trust architecture builds on its recently announced integration with Palo Alto Networks Next-Generation Firewalls.

Fleet Management Built to Scale

New fleet management groups in Semtech’s AirLink Management Service platform let administrators set the software and configuration standard for each device model, check compliance across the fleet immediately and correct devices that are not configured to the standard. AirLink Manager / AirLink Mobility Manager 2.18.1 extends that flexibility further, adding on-premises management options across the full AirLink OS portfolio, so agencies can manage fleets in the cloud or air-gapped.

Semtech at IACP 2026 Booth 2964

Greg Hill, Semtech director of product management, AirLink Networking Solutions, and Dan Robinson, Semtech director of AirLink government sales and a former police chief, will present “5G Network Slicing, Satellite, Zero Trust: The New Building Blocks of Resilient Communications” on Monday, Oct. 26 from 3:15–3:45 PM EDT. At booth #2964, attendees can see an interactive network slicing demonstration, Semtech’s cloud and on-premises management platforms and integrations with in-vehicle technology providers.

About Semtech

Semtech Corporation (Nasdaq: SMTC) is a leading provider of high-performance semiconductors powering AI data center networking, IoT connectivity and intelligent connected devices worldwide. Our global teams are committed to empowering solution architects and application developers to develop breakthrough products for the infrastructure, industrial and consumer markets. To learn more, visit Semtech.com or follow us on LinkedIn or X.

Semtech, the Semtech logo and AirLink are registered trademarks or service marks of Semtech Corporation or its subsidiaries. All other trademarks, service marks and trade names mentioned in this press release are the property of their respective owners.

SMTC-P

View source version on businesswire.com: https://www.businesswire.com/news/home/20261024697343/en/

Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.

Click for the complete disclosure

Seagate stock cratered 31% in a month on fears that a Toshiba supply surge will crush pricing, but the upcoming earnings report could either validate those fears or expose them as overblown. Watch one metric above all others to know…

Seagate Technology (NASDAQ:STX | STX Price Prediction) reports fiscal first-quarter results on Oct. 27 after the bell. The shares fell 31.7% over the past month on oversupply fears. This report has to show that AI storage demand and pricing power still hold.

Record Results Run Into a Sharp Monthlong Selloff
Last quarter was Seagate’s fifth straight beat on both EPS and revenue. Non-GAAP EPS of $5.71 exceeded the $5.09 consensus. Revenue rose 48.5% year over year to $3.629 billion. Non-GAAP gross margin reached 52.7%, and free cash flow came in above $1.1 billion.

Management guided to $4.10 billion in revenue, plus or minus $100 million, and non-GAAP EPS of $7.30, plus or minus $0.20. CEO Dave Mosley said fiscal 2027 revenue growth should outpace fiscal 2026’s 34%.

Sentiment turned soon after. Reports that Toshiba plans a major capacity ramp for AI data center HDDs raised concerns of a supply glut. The stock slid from $923.11 on Sept. 23 to $630.49. Barron’s reported that Morgan Stanley has since come out in support of the battered stock.

Analysts Expect Triple-Digit EPS Growth

Metric
Consensus
Year-Ago Actual
Implied YoY Growth

Q1 FY27 EPS
$7.4031
$2.61
183.6%

Q1 FY27 Revenue
$4.14 billion
$2.629 billion
57.5%

FY27 EPS
$36.6633
$15.58
135.3%

FY27 Revenue
$19.08 billion
$12.195 billion
56.5%

Consensus EPS sits above the guidance midpoint. It has risen since $5.8791 90 days earlier.

Price per Exabyte Will Settle the Oversupply Debate
Pricing is the first metric to watch. June-quarter price per exabyte rose 10% year over year, and management said the supply-demand gap had widened from a few quarters earlier. Management also noted some available output in fiscal Q1, priced favorably. If Toshiba’s ramp is putting pressure on deals, it should show up here first.

Contract coverage is the second test. Mosley said the vast majority of nearline exabytes are allocated into calendar 2028, and customers want to extend planning through 2029 and beyond. You should listen for whether those horizons keep stretching.

Third is the Mozaic 4 ramp. The 44-terabyte HAMR platform is scaling up with the two largest global cloud service providers, and management expected an even stronger contribution in the September quarter. Seagate is one of the picks-and-shovels AI infrastructure names we broke down in a free report on seven stocks powering the AI boom beyond the chipmakers. Seagate plans to exit calendar 2026 with 50% of HAMR exabytes on Mozaic 4. Product transitions bring yield challenges, so delivery against the about 50% operating margin guide matters.

Finally, capital returns. Debt should fall to about $2.4 billion this quarter, and management expects buybacks to increase over the next several quarters.

Locked-In Contracts Have to Beat the Glut Narrative
Seagate keeps exceeding estimates, but the stock still sold off hard on competition headlines. The options market leans cautious, with a full-chain put/call ratio of 1.06. This report gives management room to show that long-term contracted pricing drives results. If Mosley supports the 2028 allocation story with firm pricing and margin data, I think the oversupply concerns lose much of their hold.

Contact [email protected] for any questions or corrections.

Space Exploration Technologies (SPCX +1.89%) just reached a major milestone: its first profitable quarter as a public company. During the third quarter, SpaceX generated $0.35 in earnings per share. This wasn't a fluke or the result of a one-time event; it produced positive operating income, which was then boosted by various factors to deliver its first profitable quarter.

That's a major step, but does it point toward SpaceX stock being a buy right now? Let's take a look.

Image source: The Motley Fool.

SpaceX had a monster quarter  Just about everywhere you look in SpaceX's Q3 results, you see an incredibly strong business. SpaceX splits its business into three segments: Space, Connectivity, and Super Intelligence (its AI division). Its space division is exactly what you think of when you think of SpaceX: tasks like rocket and satellite launches. This is surprisingly SpaceX's smallest segment by revenue, only producing $1.8 billion compared to Connectivity's $5.2 billion and Super Intelligence's (SI) $7.6 billion during the quarter. Its Space segment was SpaceX's only unprofitable segment (from an operating income standpoint). While SpaceX will continue to pursue its space endeavors, it's not where the biggest opportunity is right now.

Instead, that lies within its connectivity and SI divisions. Connectivity is primarily SpaceX's Starlink internet service, which continues to grow at a strong pace. In Q3, it rose 69% year over year and delivered an impressive 45% operating margin. Those are fantastic numbers for any company, and if SpaceX can continue delivering those kinds of results for a few years, it will help build SpaceX into a solid and sustainable business.

SPCX Space Exploration Technologies$147.49+$2.74 (+1.89%)

NASDAQ · As of 4:00 PM ET 10/23/26

However, SI stole the show. In Q3, its revenue rose from $813 million last year to $7.56 billion -- 830% growth. That's downright incredible and shows how quickly its AI business is growing. It even turned a slight profit -- generating $431 million in operating income. SpaceX sees this as a major opportunity and spent a jaw-dropping $16.4 billion on capital expenditures this quarter in its SI division alone. That's a major bet on its AI capabilities, but if SpaceX sees how large the market opportunity is, then spending big to capture it makes sense. 

Overall, investors couldn't have asked for much better of a quarter from SpaceX, but does all of this success translate into the stock being a buy? After all, it's still very highly valued.

SpaceX isn't cheap This is the first profitable quarter SpaceX has delivered, so using the $0.35 in earnings per share to value the business isn't helpful. Instead, if we multiply it by four to annualize it, we can get a better idea of what this indicates. Following its monster quarter, SpaceX stock spiked to about $160 per share. If it can generate $0.35 in earnings per share per quarter for a full year and the stock price stays flat, that would price the stock at about 114 times earnings -- not a cheap price tag.

With most big tech stocks trading around 30 times earnings, SpaceX will need to 3.6x its earnings to reach a reasonable price tag. So, while it's on the right track, I don't think it's a cheap stock by any means. But does that mean you shouldn't buy it? I don't think so. 

SpaceX may be a somewhat polarizing stock, but if you believe in its future, then I think there's enough signals here to warrant buying the stock and holding on to it for the long term. Its AI division has strong potential, and its connectivity division will provide solid growth and cash flows as it expands. Eventually, its space business will take off (pun intended), leading to more growth from that sector as well. I think all of this adds up to a business that is becoming more attractive as an investment, but it still has a lot of work to do before it has a more reasonable valuation. 

Meta Platforms (NASDAQ: META) could rally to $1,000 after completing a potential correction, according to a long-term technical analysis of its rising price channel.

The analysis, shared by TradingShot in a TradingView post on October 23, projects a rebound toward the 1.618 Fibonacci extension at $1,000, provided META maintains its long-term uptrend.

TradingShot noted that Meta stock has traded within a long-term ascending channel since its 2012 initial public offering (IPO), with much of its price action remaining between the 0.5 and 1 Fibonacci levels.

META stock price analysis chart. Source: TradingView
The latest pullback follows a double-top rejection after September’s high, with the stock already testing its weekly 100-period moving average, shown by the green trend line.

However, the analysis suggests the pullback could deepen, leaving META vulnerable to a decline toward $550 to $500 as the U.S. midterm elections approach.

This range coincides with the monthly 50-period moving average (MA) and the 0.5 Fibonacci level, potentially providing a significant support zone.

A similar setup occurred in December 2018, when Facebook stock tested its monthly MA50 before recovering and eventually reaching new all-time highs. 

TradingShot identifies that correction as a potential historical fractal for the current price action. If the pattern repeats, META could bottom near the projected support zone before resuming its long-term advance.

However, historical comparisons don’t guarantee the same outcome, and a sustained break below support would weaken the bullish outlook.

Despite the potential near-term downside, TradingShot’s long-term Meta stock price prediction remains bullish, with the 1.618 Fibonacci extension pointing to a target of $1,000.

From its October 23 closing price of $642, the target represents approximately 55.6% upside. Reaching that level would require Meta to recover from its current pullback and resume its advance within the ascending channel.

The monthly relative strength index (RSI) provides another potential bullish signal. If the indicator falls to 40 before META tests its monthly MA50 or reaches $550. 

Such a reading could signal a potential recovery, although it would not confirm that a reversal had begun.

Meta’s financial performance will also influence whether the stock can recover and sustain its longer-term uptrend.

The company reported third-quarter 2026 revenue of $64.60 billion on October 21, up 26% year over year. Advertising remained strong, with ad impressions increasing 10% and the average price per advertisement rising 14%. Meta also reported 3.64 billion daily active people across its family of applications in September.

However, total costs and expenses increased 68% to $51.61 billion, including a $9.89 billion legal charge related to an agreement with 52 U.S. state attorneys general. Meta reported operating income of $12.99 billion and negative free cash flow of $2.12 billion for the quarter.

The company expects fourth-quarter revenue of $73 billion to $76 billion and full-year 2026 expenses of $175 billion to $179 billion. Capital expenditure is projected at $135 billion to $145 billion this year, reflecting continued investment in artificial intelligence infrastructure and other initiatives.

Meta said its AI investments are already generating additional advertising revenue through stronger engagement, improved recommendations, and more efficient monetization. 

Sustaining that growth while managing infrastructure costs will be crucial to its longer-term performance.

Featured image via Shutterstock

Best Crypto Exchange for Intermediate Traders and Investors

Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

Copy top-performing traders in real time, automatically.

eToro USA is registered with FINRA for securities trading.

30+ million
Users worldwide

eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more.

Join Finbold's newsroom, become a Sales Executive today!

Apply now to join Finbold as a crypto/finance news writer!

Time for me to upgrade Tesla back to a Buy. The thesis is getting well supported by its AI transformation and improved optimism over a potential SpaceX merger. FSD adoption is accelerating quickly, with over 75% of new North American deliveries subscribing and FSD ARR possibly reaching $1 billion. Energy storage and FSD/robotaxi are emerging as pivotal growth drivers, but automotive remains the primary revenue source for the next 12–24 months.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Alphabet To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Alphabet between May 19, 2026 and July 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - October 24, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Alphabet Inc. (""Alphabet" or the "Company") (NASDAQ: GOOGL) and reminds investors of the November 30, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that the Gemini 3.5 Pro was delivering disappointing training results; (2) that, as a result, the launch of Gemini 3.5 Pro would be significantly delayed; and (3) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On July 16, 2026, Bloomberg reported that Google is "months behind schedule on delivering Gemini 3.5 Pro, its most powerful flagship AI model" due to the Company's ongoing coding efforts. On this news, Alphabet's Class A common stock price fell $16.46, or 4.4%, to close at $354.46 per share on July 16, 2026, on unusually heavy trading volume.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Alphabet's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Alphabet class action, go to www.faruqilaw.com/GOOGL or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Frequently Asked Questions (FAQ) for Investors Regarding the Alphabet Securities Class Action Lawsuit:

What is the Alphabet securities fraud lawsuit about?

Faruqi & Faruqi, LLP has filed a securities class action lawsuit against Alphabet Inc. (NASDAQ: GOOGL) on behalf of investors who purchased Alphabet securities during the Class Period. The lawsuit alleges that Alphabet and certain of its officers made materially misleading statements or omissions regarding the Company's business, operations, and prospects. Specifically, the complaint alleges that Alphabet's Gemini 3.5 Pro model was delivering disappointing training results and that, as a result, the launch of Gemini 3.5 Pro would be significantly delayed. The lawsuit further alleges that these undisclosed problems were revealed on July 16, 2026, when Bloomberg reported that Google was allegedly months behind schedule in delivering Gemini 3.5 Pro due to ongoing coding efforts, causing Alphabet's Class A common stock to fall $16.46 per share, or approximately 4.4%, on unusually heavy trading volume.

Who may be eligible to participate in the lawsuit?

Investors who purchased or acquired Alphabet Inc. (NASDAQ: GOOGL) Class A common stock between May 19, 2026 and July 16, 2026, inclusive, may be eligible to participate in this securities class action lawsuit. The Class Period begins on May 19, 2026, and ends on July 16, 2026, the date on which the allegedly corrective information was disclosed and the stock price declined sharply. Eligible investors are not required to seek appointment as lead plaintiff in order to participate in the lawsuit or share in any potential recovery. Class members who do not take any action may still be included in the class and bound by any judgment or settlement, subject to the requirements of the applicable court order.

What is a lead plaintiff, and how can I seek appointment?

A lead plaintiff is a court-appointed representative who acts on behalf of all class members in directing the litigation, including making decisions regarding litigation strategy, the selection and oversight of counsel, and the approval of any settlement. Any investor who purchased Alphabet Class A common stock during the Class Period may move the court for appointment as lead plaintiff, but must do so no later than November 30, 2026. The lead plaintiff is typically the class member or group of members with the largest financial interest in the litigation who also satisfies the requirements of Federal Rule of Civil Procedure 23. Importantly, investors are not required to serve as lead plaintiff to share in any recovery that may be obtained; class members who take no action may still be eligible to participate in any settlement or judgment.

Why should investors contact Faruqi & Faruqi, LLP?

Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased Alphabet securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/320194

Source: Faruqi & Faruqi LLP

Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Chip stocks have been under pressure recently. During Thursday's trading session, the Philadelphia Semiconductor Index plunged by nearly 7%, and all 30 of the index's stocks finished the day in the red. Sector leader Nvidia (NVDA -0.59%) fell about 4.5%, as investors seem increasingly skeptical that the AI spending spree will last for years.

On that same day, Nvidia's CEO Jensen Huang said in an interview that demand from "neoclouds," companies that rent out Nvidia-powered computing capacity, is off the charts. But he also said that the money needed to build the capacity the market demands is far greater than what is actually available.

Image source: Getty Images.

Huang's proposed solution is to turn Nvidia's chips into what he calls a "financeable asset."

What exactly would this mean?In simple terms, Huang wants to convince lenders to use the company's chips as collateral to secure loans for AI infrastructure, much like a vehicle secures an auto loan. Nvidia has been working with several investment banks for months to help mobilize more than $500 billion in financing for AI infrastructure.

Historically, chips have been a rapidly depreciating asset. Just think of how quickly the average laptop loses value and becomes obsolete, as a simplified example. But Huang argues that Nvidia's chips retain their value because they're productive, durable assets that can be transferred from one customer to another. Huang pointed out that rental prices for Nvidia's older H100 chips actually increased between Oct. 2025 and March 2026.

Some headlines have compared Huangis proposal to securing a mortgage, but as a financial planner, I think a car loan is a better comparison. A home is an appreciating asset. This is why home mortgage interest rates are generally lower than car loan rates. If the borrower can't pay back the loan, the lender can foreclose, sell the home, and (usually) recoup all of its money.

On the other hand, cars lose value over time, but lenders are more than willing to finance them because they know roughly how fast a car loses value. When it comes to AI chips, the question is whether their depreciation is predictable. Huang has said that Nvidia's chips can generate revenue for over a decade, but many in the industry are more skeptical; to be fair, computing hardware is typically depreciated over just three or four years. So, there are a lot of details to work out when it comes to the question of "what happens if something goes wrong and a loan isn't paid back?"

What this means for investorsHuang makes the point that demand isn't the problem and that helping its customers address their capital constraints could increase order volume.

On the other hand, this seems to make investors uneasy, and it's not hard to see why. Nvidia is effectively helping its customers borrow money to buy its products, and it has said it may guarantee part of the chips' future value to make that happen. The more of Nvidia's growth depends on its customers' ability to borrow money, the more exposed it will be if a credit crunch comes.

The bottom line is that Nvidia remains the dominant supplier, and demand isn't likely to disappear anytime soon. But like many investors, I'll be watching the credit markets closely. The soaring bond yields of the heavily indebted neoclouds tell us that the appetite for lending for AI infrastructure before there's real cash flow is declining. The AI build-out now depends heavily on borrowed money, and it looks like that won't change anytime soon. When you're deciding whether to buy shares of any AI infrastructure companies, keep this in mind as a risk factor.

Visa reports Q4 earnings on Oct. 27 after a four-quarter winning streak, but a richly valued stock, rising costs, and unproven stablecoin bets mean the company needs more than another beat to justify where shares are trading.

Visa (NYSE:V | V Price Prediction) reports financial fourth-quarter results on Tuesday, Oct. 27. The stock is up 12.83% over the past month. Dividends, stablecoins and margins will decide whether that run holds.

Four Straight Beats, but Costs Are Climbing Faster
Last quarter, Visa earned $3.32 per share on $11.63B in net revenue. Both numbers beat consensus of $3.23 and $11.40B, and it was the company’s 4th straight EPS beat. Quarterly payments volume crossed $4 trillion for the first time, and value-added services revenue rose 34% in constant dollars.

Expenses grew faster than revenue. Non-GAAP operating expenses rose 17% and client incentives grew 18%. Visa also recorded $563 million in severance after cutting jobs, mostly in technology and product teams.

For Q4, management forecast net revenue growth to the high end of low double digits and EPS growth to the low end of mid-teens. Shares are up 17% year to date.

What Analysts Expect for Q4 and the Full Year

Metric
Consensus
Prior Year Actual
Implied YoY Growth

Q4 FY2026 EPS
$3.4317
$2.98
15.2%

Q4 FY2026 Revenue
$12.09B
$10.724B
12.7%

FY2026 EPS
$13.2298
$11.47
15.3%

FY2026 Revenue
$45.78B
$40.0B
14.4%

Dividend Hike, Stablecoin Traction, and Incentive Creep
Dividends: Last October, Visa raised its quarterly dividend 14% to $0.67, and it has paid that amount ever since. Visa usually announces its annual increase with the Q4 report. It also has $28.4B left on its buyback authorization after spending $4.9B on repurchases in Q3. The size of the raise is the main thing to watch.

Crypto: Visa launched the Visa Stablecoin Platform for minting, moving, and managing stablecoins. It also joined Open Standard, which plans to issue OpenUSD. The CEO acknowledged that stablecoins have “yet to scale beyond a few use cases.” You should listen for hard numbers on settlement volume or client adoption.

Margins: Management expects Q4 client incentive growth to come in slightly above Q3 on a nominal basis. It also expects to have renewed about 20% of payments volume by financial year-end. Q4 opex growth should land in the low double digits, partly because some marketing spending moved out of Q3. On the July call, the CFO said Visa expects “to continue to deliver strong margins into the future.” The first FY2027 outlook will test that claim, especially with lower small-merchant interchange rates taking effect in October 2026.

Premium Valuation Leaves Little Room for Error
Visa trades at a P/E of 35 and carries 36 Buy ratings. Beating estimates has rarely moved the stock higher. After its five beats since Q2 FY2025, shares averaged a -1.52% move the next day. A solid dividend increase, real stablecoin numbers, and a credible FY2027 margin plan are what can carry this year’s rally further.

Contact [email protected] for any questions or corrections.

BlackRock TCP Capital remains a sell as structural issues and sector headwinds persist despite a deep discount to NAV. TCPC's portfolio restructuring, including a major asset sale at a discount, alleviated leverage but signals ongoing vulnerability and potential for further sales. Dividend yield stands at 16.5% and appears sustainable into 2027, but net investment income may decline before any recovery materializes.

American Express Co. NYSE: AXP reported third-quarter 2026 earnings before the opening bell on Oct. 23. The results were solid. Yet when the market opened, AXP was the worst-performing stock in the Dow Jones Industrial Average (DJIA).

American Express Today

AXP

American Express

$313.10 -12.07 (-3.71%)

As of 10/23/2026 03:59 PM Eastern

This is a fair market value price provided by Massive. Learn more.

$290.97▼

$387.491.21%

19.00

$364.89

Investors who follow American Express have seen this movie before. The company delivers strong quarterly results, and the stock sells off anyway. The only questions are how long the selling will last and whether it should scare away long-term investors.

Get American Express alerts:

The company’s announcement of a 5% workforce reduction may help explain the selling this time. Job cuts rarely make for a feel-good headline.

However, the restructuring charge was funded by a one-time gain. That gain came from selling the company’s stake in Global Business Travel Group NYSE: GBTG.

In other words, management used a windfall to make the business leaner. Furthermore, the company said they intend to use the savings to return value to shareholders.

A more likely driver of the pullback is the macroeconomic picture. That matters because of what American Express represents. Its customer base skews toward upper-income consumers and business customers. Those groups do the majority of the spending in today’s economy. That’s particularly true in travel and entertainment (T&E).

Record Revenue Shows the Premium Consumer Is Still SpendingTo oversimplify it, as these consumers go, so goes the economy. Investors treat Amex as a real-time read on that consumer. Any hint of fatigue gets priced in quickly. However, at least for now, the AXP earnings report suggests that spending is stable.

American Express posted record third-quarter revenue of $20.1 billion, up 9% year-over-year. Diluted earnings per share (EPS) rose 31% to $5.42. Excluding the GBTG gain and restructuring charge, adjusted EPS was $4.68—still up 13% from $4.14 a year ago.

Total billed business grew 8% to $454 billion. Travel and entertainment spending led the way, rising 10% on a foreign exchange-adjusted basis. Airline billings jumped 13%. Within U.S. Consumer Services, T&E spending climbed 11%. That’s the premium consumer in action. These customers aren’t pulling back on discretionary spending yet.

Card fees tell a similar story. Net card fees rose 16% to nearly $3 billion. That growth reflects the refreshed U.S. Platinum Card and growth in premium card portfolios. Customers are paying higher annual fees and sticking around. About 76% of new accounts came on fee-paying products.

The pipeline looks healthy, too. Spending by Gen Z customers in U.S. Consumer Services jumped 35%. Millennial and Gen Z customers accounted for 65% of new global consumer accounts.

Raised Guidance Signals ConfidenceManagement raised its full-year 2026 EPS guidance to a range of $18.30 to $18.60 on a GAAP basis. On an adjusted basis, the range is $17.60 to $17.90. That’s up from the prior range of $17.30 to $17.90. The company also reaffirmed its outlook for 10% revenue growth.

CEO Stephen Squeri pointed to strength in billings, new acquisitions, Card Member retention, and credit quality. Management teams rarely raise guidance with one quarter left if they see storm clouds forming.

Credit Quality Is the Key DetailPerhaps the most important number in the report is the net write-off rate. It fell to 1.8% from 1.9% a year ago and 2.0% last quarter. Card balances 30 or more days past due held steady at 1.2%.

Consolidated provisions for credit losses also fell to $985 million from $1.29 billion a year ago. Part of that decline came from a $215 million reserve release tied to a model update. Still, the underlying write-off trend is moving in the right direction.

This matters for the macro debate. If upper-income consumers were feeling stress, it would show up in delinquencies first. So far, it isn’t.

Why Investors Are Selling on Good NewsSo why the selling? The commercial segment offers one clue. Commercial Services billings grew just 3%. That was held back by exits from the Lowe’s NYSE: LOW and Amazon NASDAQ: AMZN small business co-branded portfolios. Excluding those exits, growth was 5%. Small business spending on goods and services was soft, rising only 2%.

Investors may also be looking past the quarter. When the market worries about growth, it sells the bellwether first and asks questions later. That’s a behavioral reaction that long-term investors can use to their advantage.

Valuation Leaves Room for UpsideAXP stock isn’t expensive at around 19x earnings. That’s a reasonable multiple for a company with a 38% return on equity through the first nine months of 2026. Shares are also trading about 15% below their consensus price target.

American Express Company (AXP) Price Chart for Saturday, October, 24, 2026

The chart shows the stock bouncing off support near $300 in recent weeks. However, shares remain below their 50-week moving average near $334. A move back above that level would suggest the market is coming around.

The company is also returning capital. Amex repurchased $1.6 billion in stock and paid $600 million in dividends during the quarter. Its share count has fallen to 671 million from 689 million a year ago.

The early sell-off says more about macro anxiety than about American Express. Record revenue, raised guidance, and improving credit point to a premium consumer still in good shape. As long as that holds, pullbacks like this one may look like opportunities in hindsight.

Should You Invest $1,000 in American Express Right Now?Before you consider American Express, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Express wasn't on the list.

While American Express currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baidu To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Baidu between November 18, 2025 and August 17, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - October 24, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baidu, Inc. ("Baidu" or the "Company") (NASDAQ: BIDU) and reminds investors of the November 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that the Company had overstated the ability of its AI business to mitigate rapid declines in its legacy online marketing business; (2) that, as a result, the Company's revenue was reasonably likely to decline; and (3) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On August 18, 2026, before the market opened, the Company reported second quarter 2026 financial results, revealing that Baidu General Business revenue fell 4% year over year to RMB25.2 billion (or $3.71 billion), with Legacy Business revenue falling 23% year over year to RMB10.4 billion and total Online Marketing Services revenue falling 19% year over year to RMB13.1 billion. Critically, the Baidu Core AI-powered business fell 8% quarter over quarter to RMB12.5 billion (or $1.86 billion), its year-over-year growth having decelerated from 49% in the first quarter of 2026 to 25%, and its largest component, AI Cloud Infra, having fallen 17% quarter over quarter from RMB8.8 billion to RMB7.3 billion.

On this news, the price of Baidu ADS fell $13.25 per share, or 12.73%, to close at $90.87 on August 18, 2026, thereby injuring investors.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Baidu's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Baidu class action, go to www.faruqilaw.com/BIDU or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Frequently Asked Questions (FAQ) for Investors Regarding the Baidu Securities Class Action Lawsuit:

What is the Baidu securities fraud lawsuit about?

The lawsuit alleges Baidu misled investors about its AI business's ability to offset declines in its legacy online marketing business and failed to adequately disclose the risk of declining revenue.

Who may be eligible to participate in the lawsuit?

Investors who purchased or acquired Baidu (NASDAQ: BIDU) securities between November 18, 2025 and August 17, 2026 may be eligible if they suffered losses.

What is a lead plaintiff, and how can I seek appointment?

A lead plaintiff represents the proposed class during the litigation. Eligible investors must file a motion with the court by November 13, 2026. Investors may participate without serving as lead plaintiff.

Why should investors contact Faruqi & Faruqi, LLP?

Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased Baidu securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/320196

Source: Faruqi & Faruqi LLP

Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

A flashy dividend yield can mask serious cracks in a company's finances, and four well-known names are showing the same warning signs that preceded Whirlpool's sudden payout suspension earlier this year.

Retail investors talked up five hot stocks during the week (Oct. 19 to Oct. 23) on X and Reddit's r/WallStreetBets, driven by retail hype, earnings, AI infrastructure momentum, and corporate news flow.

Leading edge offerings, growing global capacity, expanding market share, and rich pricing power underscore the resilient demand for TSM's foundry capabilities. Despite macro headwinds and AI credit risks, the strong balance sheet and disciplined capex position it for multi-year, profitable growth prospects. Current consolidation and oversold technicals provide an attractive entry point at P/E of 23.57x, with TSM offering a rich upside potential to my LTPT of $702.80.

America's AI and grid buildout runs on copper, but the U.S. barely has the smelters to process it. A surprise $6 billion investment in Arizona could shift that equation, and five large-cap companies stand at every chokepoint between the mine…

Power delivery is the part of the data center push that gets electricity from a power plant to a rack of servers: turbines, transformers, switchgear, connectors and miles of cable. Nearly every piece of it runs on copper, and the U.S. is short on the smelters and refineries that turn mined ore into usable metal.

On October 22, 2026, Grupo México told analysts it expects to spend $4 billion to $6 billion over the next three years on its U.S. unit, Asarco. The plan includes expanding the Ray and Silver Bell mines in Arizona and restarting the Hayden smelter and refinery, Reuters reported. That compares with just $101 million of Asarco spending in 2024, roughly 13 to 20 times that pace on an annual basis.

A restarted Hayden could process 1.4 million metric tons of copper concentrate a year. Those figures describe potential capacity, and the projects still need feasibility studies, permitting, financing, and construction decisions. Below are five NYSE-listed companies that supply this layer, starting with the metal and working toward the data hall. Each is a large cap. The smallest, Hubbell (NYSE:HUBB | HUBB Price Prediction), is worth about $23.7B, so none of them belongs in the speculative category.

Freeport-McMoRan Controls Most of America’s Refined Copper
Freeport-McMoRan (NYSE:FCX) digs copper ore out of the ground, grinds it into concentrate, then smelts and refines it into nearly pure copper. Wire makers turn that metal into building cable, transformer windings and bus bars (the thick copper strips that carry heavy current inside electrical gear). Freeport accounts for about 70% of total U.S. refined copper production. Its smelter in Arizona is one of just two operating smelters in the country.

In the second quarter, Freeport posted adjusted EPS of $0.74, beating the $0.62 consensus. Revenue of $7.03B also came in above the $6.75B estimate. Its realized copper price was $6.17/lb vs $4.54/lb a year earlier. Chief Executive Kathleen Quirk linked that demand straight to this layer: “As we speak with our customers across the U.S., they continue to report robust copper demand and order books associated with AI data centers and related energy infrastructure.”

Bull case: Domestic refining is the limited step, and Freeport already owns it. Quirk said possible qualification for a Section 45X production tax credit “could equate to about $500 million a year.” Risk: Indonesia is still recovering from the September 2025 Grasberg mud rush, which pushed revenue down 7.3% year over year. More supply from projects like Hayden could also weigh on prices if production eventually grows faster than demand. The stock closed at $65.18 on October 23. That’s down 6.27% over the past week but still up 29.53% for the year.

Southern Copper Is Grupo México’s Listed Arm, Minus the Arizona Projects
Southern Copper (NYSE:SCCO) mines, smelts and refines copper in Mexico and Peru. It sells cathode, the refined plates that end up in grid conductors and data center power systems. Grupo México owns 88.9% of the company. Investors should keep the two apart. The Asarco and Hayden projects go to Grupo México’s U.S. subsidiary, which is a separate entity. An SCCO share gives you exposure to the Mexican and Peruvian assets only.

Those assets are making a lot right now. Third-quarter GAAP EPS of $2.15 beat the $1.95 consensus. Revenue rose 39.1% to $4.70B, above the $4.41B estimate. Net margin widened to 38.4% (vs 32.8%). After by-product credits, operating cash cost fell to $0.09 per pound of copper. Chief Executive German Larrea called it a “record for net sales, adjusted EBITDA and net income.”

Bull case: Southern Copper believes it holds the industry’s largest copper reserves and is working toward 1.6 million tonnes of copper annually. Its Tia Maria project was 49.6% complete as of September 30, 2026. Risk: Copper production is down 2.9% year to date because of lower Peruvian ore grades. Tia Maria’s startup also was delayed from the fourth quarter of 2027 to the first half of 2028. The shares fell 7.73% over the past week and are still up 34.98% year to date.

GE Vernova Builds the Power Plant and the Substation
GE Vernova (NYSE:GEV) makes the heavy equipment that generates electricity and moves it around. Its gas turbines spin generators. Its transformers step voltage up for long-distance lines and back down for local use. Its switchgear works like a giant breaker panel that routes power and isolates faults. That matters because, according to a 2024 Lawrence Berkeley National Laboratory report, data centers could use between 6.7% and 12% of total U.S. electricity by 2028.

Second-quarter revenue rose 21.8% to $11.10B, beating the $10.77B estimate. Orders hit $24.20B (+88% organic), and total backlog reached $176B. Electrification, the grid-gear segment, grew revenue 68% to $3.6B. Chief Executive Scott Strazik spelled out how much data centers now matter: “About $5 billion of our orders the first half of the year with data centers on the about $14 billion of orders in total in the first half.”

Bull case: GE Vernova sells at both ends of the bottleneck. Gas gigawatts under contract rose from 100 to 116 gigawatts sequentially, and the Electrification equipment backlog grew 69% to $40.6 billion. Risk: Wind revenue fell 10% in the quarter, and offshore projects face cost pressure. The stock also swings with sentiment around AI spending. It dropped 11.53% over the past week, a decline Barron’s linked to AI financing fears.

Eaton Wires the Data Hall From Utility Feed to Server Rack
Eaton (NYSE:ETN) supplies the equipment between the utility’s connection and the servers. That includes switchgear, backup power systems and busways, which are enclosed metal bars that carry power across a building in place of bundles of cable. Its $9.55B purchase of Boyd Thermal, closed in March 2026, added liquid cooling, the plates and pumps that draw heat off AI chips.

Second-quarter adjusted EPS of $3.15 beat the $3.08 estimate, and revenue rose 21.4% to $8.53B. Organic growth of 14% came in above the high end of guidance. Rolling 12-month orders in Electrical Americas rose 41%. Eaton’s chief executive described the demand runway this way: “Total U.S. data center backlog has grown to 307 gigawatts or 15 years of backlog at 2025 build rates, up from 12 years in our last update.”

Bull case: Eaton raised its full-year adjusted EPS guidance to $13.40-$13.60. It now sells both the power gear and the cooling inside a hyperscale facility. Risk: Long-term debt rose to $18.5B (from $8.8B YE2025), interest expense climbed to $201M, and the company still has to integrate Boyd and spin off its Mobility business. The stock fell 16.56% over the past month and is down 0.6% over one year.

Hubbell Supplies the Grid’s Nuts, Bolts and Connectors
Hubbell makes the hardware that holds transmission lines, substations and distribution poles together. It also makes the connectors, fittings and wire management products that join cables inside buildings. One example is its DMC connector, which management said replaces a field weld by crimping onto a bus bar. That saves limited skilled labor on site.

Second-quarter adjusted EPS of $5.52 beat the $5.38 estimate. Revenue rose 15.3% to $1.71B, with 10% of that growth organic. Electrical Solutions data center sales jumped approximately 65%. Chief Executive Gerben Bakker said, “We continue to believe utility T&D markets are in the early stages of a multiyear investment cycle and we are investing proactively in additional capacity to serve the long-term needs of our customers.”

Bull case: Hubbell raised 2026 adjusted EPS guidance to $20.25-$20.55. It also referenced a $1.5 billion high-voltage transmission opportunity over 10 years, with its first 765 kV win due to start shipping in 2027. Risk: The roughly $3.0 billion NSI Industries deal drove total debt to $5.37B and net debt-to-capital to 52%. GAAP net income was delayed 1.6%. The market has also priced the story cautiously, with the stock up just 1.8% year to date.

Where This Layer Goes From Here
Grid gear and data center orders are piling up faster than the copper supply chain behind them can grow, and Grupo México’s Arizona plan is the latest response to the U.S. refining gap. Freeport and Southern Copper are making more as copper remains tight. GE Vernova, Eaton and Hubbell are turning record backlogs into revenue. In the coming months, keep an eye on Hayden’s feasibility milestones, Freeport’s Grasberg ramp, and the next round of backlog figures from the equipment makers to see whether this bottleneck is starting to ease.

The power, cooling, and connector suppliers behind this expansion are exactly the kind of picks-and-shovels names we profiled in a free guide to non-chipmaker stocks, which you can download here: 7 Stocks Powering the AI Boom (That Aren’t Chipmakers).

Contact [email protected] for any questions or corrections.

CrowdStrike's CEO just warned that newly discovered flaws in the software powering most of the internet will trigger a wave of break-ins, and the stock market rewarded that forecast immediately. Whether investors are buying a real threat or a vendor's…

On Friday, October 23, 2026, CrowdStrike (NASDAQ:CRWD | CRWD Price Prediction) chief executive George Kurtz gave a television interview. He said newly disclosed flaws in PHP, the programming language behind nearly 70% of websites, will lead to a surge of break-ins. “You’re going to see a lot of breaches happening in the coming months from this,” he said, adding, “This is part of the long tail of these vulnerabilities that we see.”

Investors read the warning as a sales forecast. CrowdStrike rose $19.63, or 8.25%, to $257.57, valuing the company at $264.30 billion. Palo Alto Networks (NASDAQ:PANW) gained $25.63, or 7.22%, to $380.55.

What the PHP Flaws Actually Put at Risk
The federal cyber agency’s October 21 alert covered two critical PHP flaws, each rated 9.2 on the CVSS severity scale (a 0 to 10 danger score). Either one lets an attacker who has not logged in run code remotely on a web server, and PHP also disclosed a third remote-code-execution flaw.

The agency told operators to “Apply the patch immediately, prioritizing internet-facing systems” and to take unpatchable systems offline. Its October 23 revision reported no observed exploitation in the wild, though millions of hacking attempts followed while websites worldwide went offline as operators struggled, and SoftBank suspended its emergency alert system for mobile users.

Kurtz said tens of millions of servers are exposed and that AI-powered attacks CrowdStrike tracked doubled every month from July through September, while he put no figure on damage and named no company at risk.

Who Gets Paid When a Server Flaw Spreads
A flaw turns into revenue through emergency patching, incident response, managed detection and, eventually, platform consolidation. A long tail spreads that demand over months, so booking timing is uncertain.

CrowdStrike protects endpoints and cloud workloads, the layer closest to a compromised server, and sells incident response. Professional services revenue hit a record $71 million last quarter, a small slice of $1.47 billion in total revenue.

Palo Alto’s strength is the network. Chief executive Nikesh Arora said its firewalls can push protections for new flaws in under four hours, versus a 55-day standard patch time, which suits attacks arriving from the internet.

Okta (NASDAQ:OKTA) rose 5.82%, and Datadog (NASDAQ:DDOG) gained 4.62%, as traders bought shares across the sector.

Why a Vendor’s Warning Deserves a Discount
A security CEO forecasting breaches has a commercial interest in that forecast. Arora made the same pitch in September, predicting “some major breaches in the coming years” and calling that “a tailwind for the industry as a whole.”

Much of that story is likely priced in, because CrowdStrike is up 119.79% year to date and Palo Alto 106.6%, although CrowdStrike still closed about 10% below its $286.99 52-week high.

Palo Alto’s intraday high of $381.49 sat about 12% under its $432.33 peak. If the attempts don’t turn into confirmed breaches, investors are likely to discount further warnings, and the one-day gains may fade.

What Could Move CrowdStrike Before Its December Report
CrowdStrike’s one-day spike ran ahead of the evidence. The business is strong, with ARR of $5.84 billion growing 25%, but a forecast added 8.25% without one confirmed breach.

A TV investing club reduced its stake to 4.25% of its portfolio the same day, locking in about 187% in profits.

Palo Alto’s network layer fits server-side attacks, and it reports first, on Wednesday, November 18. It guided to revenue of $3.300 billion to $3.310 billion, non-GAAP EPS of $0.96 to $0.98, and Next-Generation Security ARR of $9.54 billion to $9.56 billion.

The trigger is a federal alert revision confirming exploitation, or PHP-linked breach disclosures, before CrowdStrike’s estimated December 1 report. Without either, CrowdStrike is likely to give back much of the $19.63.

Contact [email protected] for any questions or corrections.

SLB N.V. is upgraded from neutral to bullish after Q3 results signal an end to earnings declines and renewed growth momentum. Q3 delivered double beats on revenue and EPS, with all four divisions expanding margins sequentially and strong performance outside the Middle East. SLB guides for ~$10B Q4 revenue despite flat Middle East activity, with 2027 EPS projected to grow 30% YoY and valuation returning to historical norms.

1.57K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in SYF over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Incyte (Nasdaq:INCY) and Genmab A/S (Nasdaq:GMAB) today announced a clinical trial collaboration to evaluate INCB161734, Incyte’s investigational, potent and selective KRAS G12D inhibitor, in combination with petosemtamab, Genmab’s investigational IgG1-bispecific antibody targeting the epidermal growth factor receptor (EGFR) and leucine-rich repeat containing G-protein-coupled receptor 5 (LGR5), and standard-of-care chemotherapy as a first-line treatment for patients with metastatic colorectal cancer harboring KRAS G12D mutation, an area with substantial unmet medical need.

“Metastatic colorectal cancer remains difficult-to-treat, underscoring the importance of evaluating novel combinations grounded in complementary scientific approaches with the potential to enhance efficacy,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. “Our collaboration with Genmab will explore the potential of combining KRAS G12D inhibition with LGR5-targeted EGFR inhibition and standard-of-care chemotherapy, with the goal of advancing a new first-line treatment approach for patients with metastatic colorectal cancer.”

“This collaboration supports our broader development strategy for petosemtamab as we explore its potential across treatment settings and in novel combinations,” said Judith Klimovsky, M.D., Executive Vice President and Chief Development Officer, Genmab. “Partnering with Incyte enables us to evaluate this investigational combination in patients with KRAS G12D-mutated metastatic colorectal cancer, reflecting our commitment to research collaborations aimed at expanding potential treatment options for more patients.”

Under the collaboration, Genmab will conduct the Phase 1/2 study evaluating INCB161734 in combination with petosemtamab and standard-of-care chemotherapy in patients with KRAS G12D-mutated mCRC in the first-line setting. Incyte will co-fund the study and provide clinical supply of INCB161734.

KRAS mutations occur in approximately 40% of colorectal cancers, with G12D being the most common KRAS mutation. These cancers are associated with poor prognosis, underscoring the need for new treatment approaches. The collaboration reflects a shared focus on investigating whether agents with distinct and potentially complementary mechanisms, combined with standard-of-care chemotherapy, may offer a path toward a new treatment option for patients with KRAS G12D-mutated metastatic colorectal cancer.

About INCB161734

INCB161734 is an investigational, novel, selective and orally bioavailable small molecule ON/OFF KRAS G12D inhibitor. KRAS is one of the most frequently altered oncogenic drivers across solid tumors, and the KRAS G12D mutation is among the most common KRAS alterations, occurring in approximately 40% of pancreatic ductal adenocarcinoma (PDAC) cases and approximately 15% of colorectal cancer (CRC) cases.

INCB161734 is being evaluated in the global Phase 3 DAWN-303 (NCT07522073) study which is currently enrolling patients with previously untreated KRAS G12D-mutated pancreatic ductal adenocarcinoma (PDAC) to further evaluate the efficacy and safety of INCB161734 in combination with standard-of-care (SoC) chemotherapy.

INCB161734 is also being evaluated as a monotherapy and in combination with standard-of-care (SoC) chemotherapy (gemcitabine/nab-paclitaxel [GEMNabP] or modified FOLFIRINOX [mFOLFIRINOX]), in an ongoing open-label Phase 1 study across KRAS G12D-mutated solid tumors (NCT06179160).

About Petosemtamab (GEN1158)

Petosemtamab is an investigational human IgG1-based bispecific antibody targeting the EGFR and the LGR5 and designed to support multiple anti-tumor mechanisms. It inhibits EGFR-mediated signaling by engaging a unique site on the receptor to prevent ligand binding. In addition, petosemtamab triggers EGFR degradation in cancer stem-like cells expressing both EGFR and LGR5. Petosemtamab is also engineered to enhance innate immune-mediated activity through interactions with macrophages and natural killer cells. It is currently being investigated in head and neck squamous cell carcinoma (HNSCC) and other solid tumors, including colorectal cancer (CRC). Petosemtamab is being evaluated in combination with chemotherapy in two Phase 3 trials in first- and second-line RAS/BRAF wild-type metastatic CRC. Please visit https://clinicaltrials.gov/ for more information.

About Incyte®

Incyte is redefining what’s possible in biopharmaceutical innovation. Through deep scientific expertise and a relentless focus on patients, we have built an established portfolio of first-in-class medicines and an extensive portfolio of next-generation medicines across our key franchises: Hematology, Oncology and Inflammation & Autoimmunity.

To learn more, visit Incyte.com and Investor.Incyte.com. Follow us on social media: LinkedIn, X and Instagram.

About Genmab

Genmab is an international biotechnology company dedicated to improving the lives of people with cancer and other serious diseases through innovative antibody medicines. For over 25 years, its passionate, innovative and collaborative team has advanced a broad range of antibody-based therapeutic formats, including bispecific antibodies, antibody-drug conjugates (ADCs), immune-modulating antibodies and other next-generation modalities. Genmab’s science powers eight approved antibody medicines, and the company is advancing a strong late-stage clinical pipeline, including wholly owned programs, with the goal of delivering transformative medicines to patients.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark, with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com or follow us on LinkedIn, X, Facebook and Instagram.

Incyte Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding Incyte’s clinical trial collaboration with Genmab; the design, initiation, timing, conduct, sponsorship and funding of the planned studies; the potential presented by INCB161734, petosemtamab and the combination of these investigational therapies with standard-of-care chemotherapy; the potential for the combination to provide a new treatment option for patients with first-line KRAS G12D-mutated metastatic colorectal cancer; expectations regarding the initiation, timing, progress and results of ongoing and planned clinical trials for INCB161734; whether or when INCB161734, petosemtamab or any combination regimen will be approved or commercially available for use in humans anywhere in the world; Incyte’s oncology portfolio and development strategy; and Incyte’s aspirations and goals as set forth under the heading “About Incyte.”

Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors, including whether preclinical or early clinical results will be replicated in later-stage or larger clinical trials; the sufficiency of clinical trial data to meet applicable regulatory standards or warrant continued development; the ability to enroll sufficient numbers of subjects in clinical trials and to enroll subjects in accordance with planned schedules; changes in clinical development plans; actions of regulatory agencies, which may affect the initiation, timing and progress of clinical trials and regulatory approval; the efficacy or safety of Incyte’s products and product candidates; Incyte’s ability to successfully develop and commercialize its product candidates; Incyte’s reliance on third parties and collaboration partners, including with respect to the planned studies described herein; the availability and effectiveness of competing treatments; Incyte’s ability to obtain and maintain protection of intellectual property for its products and technology; greater than expected expenses, including expenses relating to clinical development, litigation or strategic activities; and those risks and uncertainties discussed in greater detail in Incyte’s reports filed with the U.S. Securities and Exchange Commission, including its annual report on Form 10-K for the year ended December 31, 2025 and its quarterly report on Form 10-Q for the quarter ended June 30, 2026. Incyte disclaims any intent or obligation to update these forward-looking statements.

Genmab Forward-Looking Statements

This Media Release contains forward-looking statements. The words “believe,” “expect,” “anticipate,” “intend” and “plan” and similar expressions identify forward-looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with preclinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab’s most recent financial reports, which are available on www.genmab.com and the risk factors included in Genmab’s most recent Annual Report on Form 20-F and other filingswith the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. Genmab does not undertake any obligation to update or revise forward looking statements in this Media Release nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law.

Genmab A/S and/or its subsidiaries own the following trademarks: Genmab®; the Y-shaped Genmab logo®; Genmab in combination with the Y-shaped Genmab logo®; HuMax®; DuoBody®; HexaBody®; DuoHexaBody®, HexElect®, and KYSO®.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261024426058/en/